Prostaglandin analogues, such as latanoprost and bimatoprost, are the go-to therapies for glaucoma therapy. They continue to ...

The FDA approved re-administration of iDose TR for patients with healthy corneas, enhancing treatment flexibility for ...

Glaukos Corporation , an ophthalmic pharmaceutical and medical technology focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced that the U.

Thank you to everyone who entered our 11th Annual Holiday Tech Giveaway! The response this year has been incredible, and we’re grateful for your continued support of Android Headlines. Winner ...